Systemic inflammation: COPD-induced chronic inflammation extends beyond the lungs, with elevated levels of pro-inflammatory cytokines (e.g., IL-6, TNF-α) impairing insulin sensitivity and promoting VF accumulation, both of which are hallmarks of metabolic dysfunction. This evidence concerns the gene INS and chronic obstructive pulmonary disease.